Humana Inc. (HUM)
Humana Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Humana Inc. (HUM) is a Medical - Healthcare Plans company based in US with a market capitalization of $48.6B. Revenue grew 10.1% year-over-year and the company generated $375M in free cash flow. This page tracks HUM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 65.68K employees · IPO Dec 31, 1981
Valuation
Valuation & price
$305.12as of May 17, 2026· -25.5% vs 52w high
31.0
P/E ratio
Latest-FY diluted EPS
2.75
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$48.6B
Market cap
10.1%
Revenue growth (YoY)
14.5%
Gross margin
$375M
Free cash flow (USD)
$8.7B
Net debt
-0.1%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed Apr 29, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Humana Inc.'s market cap?
Humana Inc. (HUM) has a market capitalization of $48.6B.
What is HUM's P/E ratio?
HUM trades at a price-to-earnings ratio of 31.0, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is HUM's price-to-book (P/B) ratio?
HUM trades at 2.75 times book value per share.
Are insiders buying HUM stock?
SEC Form 4 filings show no open-market insider buys at Humana Inc. in the last 90 days (0 sells).
Same arena
Related companies in Medical - Healthcare Plans
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.